Literature DB >> 19092634

Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.

Ghada E Esheba1, Teri A Longacre, Kristen A Atkins, John P Higgins.   

Abstract

The degree of urothelial differentiation in putative transitional (urothelial) proliferations in the female genital tract is still controversial. To further investigate the similarities (or dissimilarities) between female genital tract transitional proliferations and bladder urothelium, we evaluated the expression of S100P and GATA3, 2 proteins that we previously found to be strongly expressed in bladder urothelial tumors, in 25 benign ovarian Brenner tumors, 19 Walthard cell nests (17 tubal and 2 ovarian hilus), 1 mature teratoma with a benign urothelial proliferation, 2 proliferating (borderline) ovarian Brenner tumors, 1 malignant Brenner tumor, and 12 ovarian transitional cell carcinomas (TCC). Each lesion was also evaluated for p63 expression by immunohistochemistry. Immunostaining was performed on formalin-fixed, paraffin-embedded tissue sections using the avidin-biotin-peroxidase complex method. Eighty-eight percent of Brenner tumors were positive for S100P, whereas 96% and 100% were positive for GATA3 and p63, respectively. One of 2 proliferating Brenner tumors was positive for S100P, whereas both cases were positive for GATA3 and p63; the malignant Brenner tumor was positive for S100P and p63, but negative for GATA3. Only 17% of TCC were positive for S100p, whereas 33% and 50% of TCC were positive for GATA3 and p63, respectively. Tubal Walthard cell nests were either completely negative or showed only scattered positive staining for S100P; in contrast, 89.5% and 100% of Walthard nests, including the 2 ovarian cases were positive for GATA3 and p63. The teratoma-associated benign urothelial proliferation was also negative for S100P, but positive for GATA3 and p63. Although proliferating and malignant Brenner tumors may exhibit a more intermediate immunoprofile, expression of S100P, GATA3, and p63 by a majority of ovarian Brenner tumors underscores the similarity between these neoplasms and urothelial proliferations of bladder origin. The indeterminate phenotype seen in Walthard nests and ovarian TCC suggests that these proliferations may represent an incomplete or alternate form of differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19092634     DOI: 10.1097/PAS.0b013e3181908e24

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5.

Authors:  Tamás Zombori; Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2017-05-03       Impact factor: 3.201

2.  GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens.

Authors:  Yi Li; Hitoshi Ishiguro; Takashi Kawahara; Yurina Miyamoto; Koji Izumi; Hiroshi Miyamoto
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

3.  Cytologic features of sex cord-stromal tumors in women.

Authors:  Liz N Edmund; Abeer M Salama; Rajmohan Murali
Journal:  Cancer Cytopathol       Date:  2021-08-19       Impact factor: 4.264

4.  Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.

Authors:  Alex Chang; Ali Amin; Edward Gabrielson; Peter Illei; Richard B Roden; Rajni Sharma; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

5.  GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.

Authors:  Markku Miettinen; Peter A McCue; Maarit Sarlomo-Rikala; Janusz Rys; Piotr Czapiewski; Krzysztof Wazny; Renata Langfort; Piotr Waloszczyk; Wojciech Biernat; Jerzy Lasota; Zengfeng Wang
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

6.  The clinicopathological features of metastatic tumors of the bladder: analysis of 25 cases.

Authors:  Luhua Wang; Guoxin Song; Weiming Zhang; Zhihong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

7.  Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma.

Authors:  Rajiv Prasad Keshari; Wei Wang; Yu Zhang; Dan-dan Wang; Yuan-fang Li; Shu-qiang Yuan; Hai-bo Qiu; Chun-yu Huang; Yong-ming Chen; Jian-chuan Xia; Zhi-wei Zhou
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

8.  GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.

Authors:  Richard B Mertens; Mariza N de Peralta-Venturina; Bonnie L Balzer; David P Frishberg
Journal:  Am J Dermatopathol       Date:  2015-12       Impact factor: 1.533

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.